Merck & Co. has had a good run so far as it fights off plaintiffs saying the companys osteoporosis drug Fosamax caused them health problemsclaiming victory in five of the seven bellwether cases to go to trial.
By Cathleen FlahardyFebruary 06, 2013
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.